San Antonio Breast Cancer Symposium SABCS 2021 poster
23 Aug 2022
In this conference poster, Diaceutics revealed an increasing body of evidence demonstrating that screening and diagnosis rates for a number of different cancers (including TNBC ) dropped in the first quarter of 2020, coincident with the deployment of measures intended to mitigate the spread of COVID19 infection and showing that diagnosis rates had not returned to normal by the third quarter of 2020.
- The COVID-19 pandemic has caused nearly 695,000 deaths in the US as of 29 Sep 21
- An increasing body of evidence demonstrates that the COVID-19 pandemic of 2020 saw large reductions in the number of US patients being diagnosed with a variety of conditions including cancer, ischemic stroke, heart failure and depression
- Screening and diagnosis rates for a number of different cancers dropped in the first quarter of 2020 e.g., coincident with the deployment of measures intended to mitigate the spread of infection and that diagnosis rates had not returned to normal by the third quarter of 2020